U.S. Markets open in 2 hrs 9 mins
  • S&P Futures

    3,841.00
    +6.75 (+0.18%)
     
  • Dow Futures

    30,842.00
    -67.00 (-0.22%)
     
  • Nasdaq Futures

    13,483.50
    +122.00 (+0.91%)
     
  • Russell 2000 Futures

    2,153.20
    -10.80 (-0.50%)
     
  • Crude Oil

    52.33
    +0.06 (+0.11%)
     
  • Gold

    1,861.70
    +5.50 (+0.30%)
     
  • Silver

    25.67
    +0.12 (+0.47%)
     
  • EUR/USD

    1.2161
    -0.0013 (-0.1095%)
     
  • 10-Yr Bond

    1.0910
    0.0000 (0.00%)
     
  • Vix

    22.72
    +1.40 (+6.57%)
     
  • GBP/USD

    1.3685
    +0.0000 (+0.0027%)
     
  • USD/JPY

    103.8260
    +0.0650 (+0.0626%)
     
  • BTC-USD

    33,468.91
    +21.67 (+0.06%)
     
  • CMC Crypto 200

    678.40
    +1.50 (+0.22%)
     
  • FTSE 100

    6,650.77
    -44.30 (-0.66%)
     
  • Nikkei 225

    28,822.29
    +190.84 (+0.67%)
     

REFILE-Britain on track for spring roll-out after Oxford vaccine results, researcher says

·1 min read

(Adds dropped word in first paragraph)

LONDON, Nov 23 (Reuters) - An ambitious timeline make a COVID-19 vaccine widely available in Britain by next spring is on track after Oxford/AstraZeneca's candidate proved up to 90% effective in late-stage trials, the head of the university's Jenner Institute said on Monday.

"I think we are on track for the timeline... to start getting this vaccine rolled out from December," Adrian Hill, director of Oxford's Jenner Institute, told Reuters, adding that high-risk groups would receive shots before it was rolled out more widely to everyone in spring.

"I think that could be done. It's going to be an enormous effort... hopefully there will be vaccine available for all adults, but that's likely to be springtime rather than in January." (Reporting by Alistair Smout; editing by Alistair Smout)